These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12750472)

  • 1. Beta cell MHC class I is a late requirement for diabetes.
    Hamilton-Williams EE; Palmer SE; Charlton B; Slattery RM
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6688-93. PubMed ID: 12750472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
    de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM
    Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-tolerance and differential susceptibility to diabetes in transgenic mice expressing major histocompatibility class II genes on pancreatic beta cells.
    Götz J; Eibel H; Köhler G
    Eur J Immunol; 1990 Aug; 20(8):1677-83. PubMed ID: 2209682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male-specific beta-cell dysfunction and diabetes resulting from increased expression of a syngeneic MHC class I protein in the pancreata of transgenic mice.
    Martin L; Keller GA; Liggitt D; Oakley H; Pitts-Meek SL; Siegel MW; Terrell T; Stewart TA
    New Biol; 1990 Dec; 2(12):1101-10. PubMed ID: 1965148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
    DiLorenzo TP; Serreze DV
    Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.
    Thomas HE; Parker JL; Schreiber RD; Kay TW
    J Clin Invest; 1998 Sep; 102(6):1249-57. PubMed ID: 9739059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
    Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
    J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I epitope discovery in type 1 diabetes.
    van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
    Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-islet proliferation of cytotoxic T lymphocytes contributes to insulitis progression.
    Graham KL; Krishnamurthy B; Fynch S; Ayala-Perez R; Slattery RM; Santamaria P; Thomas HE; Kay TW
    Eur J Immunol; 2012 Jul; 42(7):1717-22. PubMed ID: 22585671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
    J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte and cDNA sequence analyses of the MHC class Ib molecule Qa1 in nonobese diabetic mice.
    Chun T; Hermel E; Gaskins HR; Aldrich CJ
    Immunogenetics; 2001 Aug; 53(6):506-10. PubMed ID: 11685462
    [No Abstract]   [Full Text] [Related]  

  • 14. Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL.
    Qin H; Trudeau JD; Reid GS; Lee IF; Dutz JP; Santamaria P; Verchere CB; Tan R
    Int Immunol; 2004 Nov; 16(11):1657-62. PubMed ID: 15466911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of beta-cell function during immune-mediated, B7-1-dependent alpha-cell destruction.
    Skak K; Haase C; Michelsen BK
    Eur J Immunol; 2005 Sep; 35(9):2583-90. PubMed ID: 16078275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.
    Liadis N; Murakami K; Eweida M; Elford AR; Sheu L; Gaisano HY; Hakem R; Ohashi PS; Woo M
    Mol Cell Biol; 2005 May; 25(9):3620-9. PubMed ID: 15831467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
    J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
    Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
    Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.